Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

GNWSF

Genenews Ltd

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

GNWSF:Genenews Ltd - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.04

EXCHANGE

OTCBB

SECTOR

Health Care

GNWSF
Genenews Ltd Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
GNWSF
Genenews Ltd Stock Information
Latest Close Price$0.04
52-Week Low/High$0.01 - $0.14
Percent Held by Institutions11.38%
Revenue$267,239
Net Income$-4,937,910
Cash Flow$-766,158
EPS-0.01%
Market Cap$542,033
PE Ratio0
PE Ratio to Industry32%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.06%
Total Return Last 12 Months-66.08%
Total Return Last 3 Years132.11%
Total Return Last 5 Years-94.00%
Latest Trade DateJan. 14, 2019
GNWSF
Genenews Ltd Dividend Payment History

No Data available for Payment History.

GNWSF
Genenews Ltd Other Details

Genenews is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. Co. has been granted two foundational U.S. patents for its core platform technology, the Sentinel Principle®, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. Co. is applying the Sentinel Principle® in areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. Co.'s product include ColonSentry™, a blood-based test to assess an individual's current risk for colorectal cancer.

Web Sitewww.genenews.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Genenews Ltd Dividend Stock News and Updates

Jan. 15, 2019CLOSE PRICE DECREASE: Genenews Ltd (OTCBB: GNWSF) on 01-15-2019 decreased close price > 10% from $0.05 to $0.04

Read more...

Jan. 12, 2019CLOSE PRICE INCREASE: Genenews Ltd (OTCBB: GNWSF) on 01-12-2019 increased close price > 10% from $0.04 to $0.05

Read more...

Jan. 11, 2019CLOSE PRICE INCREASE: Genenews Ltd (OTCBB: GNWSF) on 01-11-2019 increased close price > 10% from $0.04 to $0.04

Read more...
More Genenews Ltd Dividend News
Biotechnology Dividend Stock News and Updates

Jan. 18, 2019CLOSE PRICE INCREASE: Agenus Inc (NASDAQ: AGEN) on 01-18-2019 increased close price > 10% from $3.19 to $3.73

Read more...

Jan. 18, 2019CLOSE PRICE INCREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 01-18-2019 increased close price > 10% from $0.00 to $0.00

Read more...

Jan. 18, 2019CLOSE PRICE INCREASE: Cleveland BioLabs Inc (NASDAQ: CBLI) on 01-18-2019 increased close price > 10% from $1.32 to $1.49

Read more...
More Biotechnology Dividend News
X

Search Dividend Investor